{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:41:57Z","timestamp":1781163717607,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Intravesical administration of Bacillus Calmette\u2013Gu\u00e9rin (BCG) has proven useful for treatment and prevention of recurrence of superficial bladder cancer and in situ carcinoma. However, fatal side effects such as disseminated infections may occur. Early diagnosis and accurate therapy for interstitial pneumonitis (IP) are important because exacerbation of IP triggered by infections is the major cause of death. Although some fatality reports have suggested newly appeared IP after intravesical BCG treatment, to our knowledge, there are no reports which have demonstrated acute exacerbation of existing IP. Moreover, autopsy is lacking in previous reports. We report the case of a patient with fatal IP exacerbation after BCG instillation and the pathological findings of the autopsy.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 77-year-old man with a medical history of IP was referred to our hospital because of fever and malaise. He had received an intravesical injection of BCG 1 day before the admission. His fever reduced after the use of antituberculosis drugs, so he was discharged home. He was referred to our hospital again because of a high fever 7 days after discharge. On hospitalisation, he showed high fever and systemic exanthema. Hepatosplenomegaly and myelosuppression were also observed. Biopsies revealed multiple epithelioid cell granulomas with Langhans giant cells of the liver and bone marrow. Biopsy DNA analyses of <jats:italic>Mycobacterium bovis<\/jats:italic> in the bone marrow, sputum, and blood were negative. His oxygen demand worsened drastically, and the ground-glass shadow expanded on the computed tomography scan. He was diagnosed with acute exacerbation of existing IP. We recommenced the antituberculosis drugs with steroid pulse therapy, but he died on day 35 because of respiratory failure. The autopsy revealed a diffuse appearance of multiple epithelioid cell granulomas with Langhans giant cells in multiple organs, although BCG was not evident.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We report the first case of acute exacerbation of chronic IP by BCG infection. This is also the first case of autopsy of a patient with acute exacerbation of existing IP induced by intravesical BCG treatment. Whether the trigger of acute IP exacerbation is infection or hypersensitivity to BCG is still controversial, because pathological evidence confirming BCG infection is lacking. Physicians who administer BCG against bladder cancer should be vigilant for acute exacerbation of IP.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-05396-7","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T11:03:09Z","timestamp":1601377389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Disseminated Bacillus Calmette\u2013Gu\u00e9rin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review"],"prefix":"10.1186","volume":"20","author":[{"given":"Gen","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8946-9475","authenticated-orcid":false,"given":"Ryota","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuta","family":"Toru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"issue":"2","key":"5396_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette\u2013Gu\u00e9rin in the treatment of superficial bladder tumors. J Urol. 1976;116(2):180\u20133.","journal-title":"J Urol"},{"issue":"6","key":"5396_CR2","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/S0022-5347(06)00264-3","volume":"175","author":"MP Koya","year":"2006","unstructured":"Koya MP, Simon MA, Soloway MS. Complications of intravesical therapy for urothelial cancer of the bladder. J Urol. 2006;175(6):2004\u201310.","journal-title":"J Urol"},{"issue":"3","key":"5396_CR3","first-page":"230","volume":"19","author":"SJ Um","year":"2009","unstructured":"Um SJ, Lee SK, Yang DK. Hypersensitivity pneumonitis following intravesical bacille Calmette\u2013Guerin immunotherapy for superficial bladder cancer. J Investig Allergol Clin Immunol. 2009;19(3):230\u20132.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"17","key":"5396_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/MD.0000000000000119","volume":"93","author":"MA Perez-Jacoiste Asin","year":"2014","unstructured":"Perez-Jacoiste Asin MA, Fernandez-Ruiz M, Lopez-Medrano F, Lumbreras C, Tejido A, San Juan R, Arrebola-Pajares A, Lizasoain M, Prieto S, Aguado JM. Bacillus Calmette\u2013Guerin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine (Baltimore). 2014;93(17):236\u201354.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"5396_CR5","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","volume":"147","author":"DL Lamm","year":"1992","unstructured":"Lamm DL, van der Meijden PM, Morales A, Brosman SA, Catalona WJ, Herr HW, Soloway MS, Steg A, Debruyne FM. Incidence and treatment of complications of bacillus Calmette\u2013Guerin intravesical therapy in superficial bladder cancer. J Urol. 1992;147(3):596\u2013600.","journal-title":"J Urol"},{"issue":"22","key":"5396_CR6","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1056\/NEJMcpc1504839","volume":"373","author":"JL Cho","year":"2015","unstructured":"Cho JL, McDermott S, Tsibris AM, Mark EJ. Case records of the Massachusetts General Hospital. Case 37-2015. A 76-year-old man with fevers, leukopenia, and pulmonary infiltrates. N Engl J Med. 2015;373(22):2162\u201372.","journal-title":"N Engl J Med"},{"issue":"4","key":"5396_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/archinte.1970.00310040115014","volume":"125","author":"RM Glasser","year":"1970","unstructured":"Glasser RM, Walker RI, Herion JC. The significance of hematologic abnormalities in patients with tuberculosis. Arch Intern Med. 1970;125(4):691\u20135.","journal-title":"Arch Intern Med"},{"issue":"3","key":"5396_CR8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0022-5347(17)37354-8","volume":"147","author":"JM Molina","year":"1992","unstructured":"Molina JM, Rabian C, D'Agay MF, Modai J. Hypersensitivity systemic reaction following intravesical bacillus Calmette\u2013Guerin: successful treatment with steroids. J Urol. 1992;147(3):695\u20137.","journal-title":"J Urol"},{"issue":"3","key":"5396_CR9","first-page":"763","volume":"135","author":"D Israel-Biet","year":"1987","unstructured":"Israel-Biet D, Venet A, Sandron D, Ziza JM, Chretien J. Pulmonary complications of intravesical Bacille Calmette\u2013Guerin immunotherapy. Am Rev Respir Dis. 1987;135(3):763\u20135.","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"5396_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1590\/S1677-55382004000500008","volume":"30","author":"EK Diner","year":"2004","unstructured":"Diner EK, Verghese M. Interstitial pneumonitis secondary to intravesical bacillus Calmette\u2013Guerin for carcinoma in situ of the bladder. Int Braz J Urol. 2004;30(5):400\u20132.","journal-title":"Int Braz J Urol"},{"issue":"2","key":"5396_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/003693309403900205","volume":"39","author":"D Lyons","year":"1994","unstructured":"Lyons D, Miller I, Jeffers A. Systemic hypersensitivity reaction to intravesical BCG. Scott Med J. 1994;39(2):49\u201350.","journal-title":"Scott Med J"},{"issue":"8","key":"5396_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.arbres.2016.01.014","volume":"52","author":"L Carrasco Hernandez","year":"2016","unstructured":"Carrasco Hernandez L, Castano Nunez AL, Rodriguez Portal JA. Hypersensitivity pneumonitis as a complication of intravesical BCG therapy for bladder cancer. Arch Bronconeumol. 2016;52(8):445\u20136.","journal-title":"Arch Bronconeumol"},{"issue":"12","key":"5396_CR13","first-page":"1383","volume":"35","author":"K Naoki","year":"1997","unstructured":"Naoki K, Yamaguchi K, Soejima K, Aoki T, Inoue T, Satou N, Shimada H, Fukunaga K, Kudo H, Kanazawa M. A case of interstitial pneumonia induced by intravesical administration of bacillus Calmette\u2013Guerin (BCG). [Japanese with English abstract.]. Nihon Kyobu Shikkan Gakkai Zasshi. 1997;35(12):1383\u20138.","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"issue":"10","key":"5396_CR14","first-page":"427","volume":"63","author":"S Nitta","year":"2017","unstructured":"Nitta S, Sakka S, Endo T, Komine M, Tsutsumi M, Nishiyama H. Fever, hepatic dysfunction and interstitial pneumonia caused by intravesical Bacillus Calmette\u2013Guerin (BCG) instillation after urethral bougie: a case report. [Japanese with English abstract.]. Hinyokika Kiyo. 2017;63(10):427\u201330.","journal-title":"Hinyokika Kiyo"},{"issue":"7","key":"5396_CR15","first-page":"493","volume":"45","author":"M Horinaga","year":"1999","unstructured":"Horinaga M, Nakamura K, Nishiyama T, Murai M. A case of interstitial pneumonitis caused by intravesical bacillus Calmette\u2013Guerin instillation. [Japanese with English abstract.]. Hinyokika Kiyo. 1999;45(7):493\u20135.","journal-title":"Hinyokika Kiyo"},{"issue":"5","key":"5396_CR16","first-page":"691","volume":"102","author":"H Uetsuki","year":"2011","unstructured":"Uetsuki H, Hirama H, Matsuoka Y, Miyauchi Y, Tsunemori H, Yamashita M, Inui M, Sugimoto M, Kakehi Y. A case with hepatitis and interstitial pneumonitis caused by intravesical bacillus Calmette\u2013Guerin (BCG) instillation. [Japanese with English abstract.]. Nihon Hinyokika Gakkai Zasshi. 2011;102(5):691\u20135.","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"issue":"10","key":"5396_CR17","first-page":"803","volume":"46","author":"A Yamamoto","year":"2008","unstructured":"Yamamoto A, Koyama R, Kido K, Koike K, Toba M, Takahashi K. Case of interstitial pneumonia induced by intravesical administration of Bacillus Calmette\u2013Guerin. [Japanese with English abstract.]. Nihon Kokyuki Gakkai Zasshi. 2008;46(10):803\u20137.","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"issue":"10","key":"5396_CR18","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/thoraxjnl-2011-201088","volume":"67","author":"B Davies","year":"2012","unstructured":"Davies B, Ranu H, Jackson M. Pulmonary complications of intravesicular BCG immunotherapy. Thorax. 2012;67(10):933\u20134.","journal-title":"Thorax"},{"key":"5396_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2466-14-35","volume":"14","author":"M Tobiume","year":"2014","unstructured":"Tobiume M, Shinohara T, Kuno T, Mukai S, Naruse K, Hatakeyama N, Ogushi F. BCG-induced pneumonitis with lymphocytic pleurisy in the absence of elevated KL-6. BMC Pulm Med. 2014;14:35.","journal-title":"BMC Pulm Med"},{"issue":"6","key":"5396_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.nefro.2016.06.001","volume":"36","author":"F Caravaca-Fontan","year":"2016","unstructured":"Caravaca-Fontan F, Cano Megias M, Sanchez-Conde M, Elias Trivino S, Fernandez-Rodriguez A, Liano F. Subacute interstitial pneumonitis due to Mycobacterium bovis after intravesical bacillus Calmette\u2013Guerin instillation in a renal transplant patient. Nefrologia. 2016;36(6):711\u20133.","journal-title":"Nefrologia"},{"issue":"6","key":"5396_CR21","first-page":"1101","volume":"28","author":"A Araki","year":"2015","unstructured":"Araki A, Abe K, Komiya A, Ogo Y. A case report of renal tuberculosis and interstitial pneumonitis caused by intravesical Bacillus Calmette\u2013Guerin (BCG) instillation. [Japanese with English abstract]. Jpn J Urol Surg. 2015;28(6):1101\u20136.","journal-title":"Jpn J Urol Surg"},{"issue":"12","key":"5396_CR22","first-page":"626","volume":"78","author":"K Kosuke","year":"2016","unstructured":"Kosuke K, Kazumasa H, Koichi M, Kensuke N, Shinsuke H, Yasuyuki H. Interstitial pneumonia induced by instillation of Bacillus Calmette\u2013Guerin (BCG) to upper urinary tract: a case report. [Japanese with English abstract.]. Nishinihon J Urol. 2016;78(12):626\u201332.","journal-title":"Nishinihon J Urol"},{"key":"5396_CR23","unstructured":"Yamashita K, Tomiyasu K, Ihara Y, Noriko Y, Sonoyama H, Toida I. The status of adverse drug reaction incidence of Immunobladder after marketing. [Japanese with English abstract.]. Ann Soc BCG BRM Immunother. 2000;24:81\u20138."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05396-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05396-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05396-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T23:16:15Z","timestamp":1632870975000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05396-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5396"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05396-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This case report was approved by Nitobe Memorial Nakano General Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s next of kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"708"}}